Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06377267
Title Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) (STROBE)
Acronym STROBE
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.